글로벌 임상 화학 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

임상 화학 분석기는 최근 수십 년 동안 주요 기술 혁신과 의료 사업 수요 확대로 인해 점점 더 인기를 얻고 있습니다. 임상 화학은 체액 검사에 초점을 맞추고 정확한 진단 정보를 제공합니다. 현대 임상 화학은 전통적인 수동 실험실 검사의 기초 위에 구축되었습니다. 그러나 기술이 발전함에 따라 검사 방법이 개발되었고, 다양한 검사는 이제 화학 분석기와 같은 복잡한 장치를 활용하여 자동화된 실험실에서 수행할 수 있습니다.

Data Bridge Market Research는 2021년에 130억 달러였던 임상 화학 시장이 2029년까지 195억 8천만 달러로 급증할 것으로 분석했으며, 2022년부터 2029년까지의 예측 기간 동안 5.25%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

Market Definition

Chemical techniques are used in clinical chemistry to determine the amounts of chemical components in body fluids. It is a branch of biochemistry that deals with the diagnostic evaluation of bodily fluids. Clinical chemistry is used to diagnose diseases, determine metabolic function, and assess the presence of medications by evaluating serum, blood, cerebrospinal fluids, plasma, and urine samples for analyte concentration.

Clinical Chemistry Market Dynamics

Drivers

• Rise in demand of clinical chemistry

In the forecast period of 2022-2029, rising demand for POCT kits and analysers for rapid detection, rising occurrences of cardiovascular disorders, diabetes, hypertension, and others, rising preferences for automated devices, and increasing government initiatives for the prevalence of better healthcare diagnostics facilities are expected to accelerate the growth of the clinical chemistry market. On the other hand, the growing number of research activities will enhance numerous prospects, resulting in the clinical chemistry market growing during the projection period.

• Rise in the geriatric population

The rising prevalence rates of lifestyle disorders like diabetes and obesity, rising healthcare spending, and the fast-growing diagnostic industry drive the worldwide clinical chemistry market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the clinical chemistry market forward.

• Prevalence of chronic ailments

The rise of clinical chemistry has recently been fueled by an increase in the frequency of chronic diseases such as cancer and diabetes, which has resulted in increased demand for faster diagnosis, technological innovations, and scientific research for future therapeutic applications. The developments give benefits such as easy parameter monitoring, automatic data gathering, and automatic variable modifications, to name a few. The whole clinical chemistry market is expected to rise in the future as healthcare and medical professionals need more automated clinical chemistry procedures. In addition, the clinical chemistry business is seeing growing demand due to rising disposable incomes and increased awareness of the need of diagnostic examinations.

Opportunities

The total clinical chemistry market is predicted to grow in the future due to an increased desire for automated clinical chemistry techniques among healthcare and medical professionals. In the coming years, government initiatives and actions to promote clinical chemistry's benefits could potentially help boost the clinical chemistry industry. Growing awareness of the importance of diagnostic tests and rising disposable incomes are driving demand in the clinical chemistry industry.

Restraints/Challenges

Unavailability of skilled professionals along with high cost of devices will hamper the growth of the clinical chemistry market in the mentioned forecast period.

This clinical chemistry market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical chemistry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Clinical Chemistry Market

The COVID-19 epidemic had a negative impact on the companies' sales. Lockdowns arising from the COVID-19 epidemic forced people to put off getting their health checked, reducing the amount of tests performed and reagent sales. However, as governments gradually loosen travel restrictions, there is a rebound in testing numbers. With the COVID-19 pandemic, dealing with infectious diseases has become a major medical concern around the world. In addition to vaccinations and therapeutic medications, there is an increasing demand for more precise and simple testing technologies as well as the expansion of testing structures.

Recent Development

• January 2019 – Hofmann-La-Roche Ltd has released COBAS PRO, an integrated solution in the Serum Work Area. This is a big milestone in laboratory diagnostics, as it can perform 2,200 tests every hour.
• February 2019 – Fujifilm Corporation and JEOL have formed a strategic partnership in the international clinical chemistry analyzer market.

Global Clinical Chemistry Market Scope

The clinical chemistry market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Clinical Chemistry Analysers
• POC Test Kits
• Clinical Chemistry Analyser Kits and Reagents

 Application

• Basic Metabolite Panel
• Liver Function Test
• Electrolyte Panel
• Kidney Function Test
• Lipid Profile
• Specialty Chemical Test
• Thyroid Profile
• Other Biochemical Tests

End-User

• Hospitals
• Pathology Laboratories
• Maternity Centres
• Outpatient Centres
• Clinics

Clinical Chemistry Market Regional Analysis/Insights

The clinical chemistry market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.

The countries covered in the clinical chemistry market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the clinical chemistry market due to the growing number of geriatric population along with adoption of innovative medical technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness and growing demand for advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

경쟁 환경 및 임상 화학 시장 점유율 분석

임상 화학 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 임상 화학 시장과 관련된 회사의 초점에만 관련이 있습니다.

임상화학 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 애벗(미국)
• 다나허(미국)
• Thermo Fisher Scientific Inc.(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 존슨앤존슨 서비스 주식회사(미국)
• 지멘스(독일)
• ELI Tech Group(프랑스)
• HORIBA, Ltd.(일본)
• 심천 Mindray Bio-Medical Electronics Co., Ltd (중국)
• Randox Laboratories Ltd. (영국)
• Ortho Clinical Diagnostics(미국)
• 노바 바이오메디컬(미국)
• 시스멕스 주식회사(일본)
• Bio Systems Diagnostics Pvt. Ltd. (인도)
• DiaSys Diagnostic Systems GmbH(독일)
• Endress Hauser Management AG(스위스)
• Diatron(헝가리)
• SFRI. (프랑스)
• EKF 메디카 코퍼레이션(영국)

SKU-53044